Sponsor

Prestige Biopharma Ltd

21 Biopolis Road, #04-24 28 Nucleos South Building Biopolis, 138567

About the sponsor

Prestige Biopharma Ltd is conducting clinical research in advanced and/or metastatic pancreatic adenocarcinoma, with a focus on patients whose disease has progressed after prior chemotherapy. The programme includes investigation of an oncology treatment given alone and in combination with gemcitabine for locally advanced and metastatic disease.

Pancreatic adenocarcinoma
Metastatic disease
Combination therapy

The sponsor’s oncology portfolio in this area centres on treatment options for difficult-to-manage pancreatic malignancy in the Singapore research setting.

About Specializations

Prestige Biopharma Ltd runs clinical trials in conditions such as Pancreatic carcinoma, Adenocarcinoma pancreas, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Pancreatic carcinoma+1

Recruiting

InvestigationalNo placebo

Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Anti-(Pancreatic Adenocarcinoma Upregulated Factor) Igg1 Humanised Monoclonal Antibody
Sponsor:Prestige Biopharma Ltd

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →